Stop Flozins in Patients Who Complain About Ketoacidosis Symptoms

July 2015

See updated FDA information (December 2015) concerning SGLT2 inhibitors (Flozins) and ketoacidosis/urinary tract infections.

Colleagues will ask you whether Invokana (canagliflozin) and other SGLT2 inhibitors or "flozins" are linked to ketoacidosis.

This seems to be a flozin class effect...and has researchers scratching their heads about the mechanism.

It's different from the ketoacidosis we typically see with VERY high blood glucose. It's often happening in patients with blood glucose levels near normal or only slightly elevated.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote